Release of endothelin-1 from human endocardium after radiofrequency catheter ablation and coronary angioplasty: Comparative results

International Journal of Cardiology

Volumn 102, Issue 2, 2005, Pages 187-193

  Davlouros, Periklis A ^a   Simeonidou, Eftihia ^a   Tsakas, Sotiris ^a   Vlachojannis, Ioannis ^a   Alexopoulos, Dimitrios ^a   Manolis, Antonis S ^a,b  

^a UNIVERSITY HOSPITAL OF PATRAS   (Greece)

^b NONE   (Greece)

Author keywords

Coronary angioplasty; Endothelin; Radiofrequency ablation

Indexed keywords

ENDOTHELIN 1;

ADULT; ARTICLE; CATHETER ABLATION; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC TEST; ENDOCARDIUM; FEMALE; HEART ARRHYTHMIA; HEART ELECTROPHYSIOLOGY; HEART MUSCLE ISCHEMIA; HUMAN; INTERMETHOD COMPARISON; KINETICS; MALE; PRESSURE; PRIORITY JOURNAL; PROTEIN SECRETION; STATISTICAL SIGNIFICANCE; TRANSLUMINAL CORONARY ANGIOPLASTY;

ARRHYTHMIA; BIOLOGICAL MARKERS; CATHETER ABLATION; CORONARY ANGIOGRAPHY; CORONARY DISEASE; ELECTROCARDIOGRAPHY; ENDOCARDIUM; ENDOTHELIN-1; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; POSTOPERATIVE PERIOD; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 20744446340     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2004.04.010     Document Type: Article

References (42)

1. E.R. Levin Endothelins N. Engl. J. Med. 333 1995 356 363
2. T.F. Luscher, and M. Barton Endothelins and endothelin receptor antagonists: therapeutic considerations for a novel class of cardiovascular drugs Circulation 102 2000 2434 2440
3. A. Inoue, M. Yanagisawa, and S. Kimura The human endothelin family: three structurally and pharmacologically distinct isopeptides predicted by three separate genes Proc. Natl. Acad. Sci. U. S. A. 86 1989 2863 2867
4. K. Saida, Y. Mitsui, and N. Ishida A novel peptide, vasoactive intestinal contractor, of a new (endothelin) peptide family. Molecular cloning, expression, and biological activity J. Biol. Chem. 264 1989 14613 14616
5. A. Malek, and S. Izumo Physiological fluid shear stress causes downregulation of endothelin-1 mRNA in bovine aortic endothelium Am. J. Physiol. 263 1992 C389 C396
6. M.J. Kuchan, and J.A. Frangos Shear stress regulates endothelin-1 release via protein kinase C and cGMP in cultured endothelial cells Am. J. Physiol. 264 1993 H150 H156
7. H. Macarthur, T.D. Warner, E.G. Wood, R. Corder, and J.R. Vane Endothelin-1 release from endothelial cells in culture is elevated both acutely and chronically by short periods of mechanical stretch Biochem. Biophys. Res. Commun. 200 1994 395 400
8. K. Hishikawa, T. Nakaki, T. Marumo, H. Suzuki, R. Kato, and T. Saruta Pressure enhances endothelin-1 release from cultured human endothelial cells Hypertension 25 1995 449 452
9. G. McClellan, A. Weisberg, D. Rose, and S. Winegrad Endothelial cell storage and release of endothelin as a cardioregulatory mechanism Circ. Res. 75 1994 85 96
10. A. Tahara, M. Kohno, and S. Yanagi Circulating immunoreactive endothelin in patients undergoing percutaneous transluminal coronary angioplasty Metabolism 40 1991 1235 1237
11. S. Ameli, S. Kaul, L. Castro, C. Arora, A. Mirea, and P.K. Shah Effect of percutaneous transluminal coronary angioplasty on circulating endothelin levels Am. J. Cardiol. 72 1993 1352 1356
12. Z.S. Kyriakides, M. Markianos, E. Iliodromitis, D. Tsiapras, N. Fragakis, and D.T. Kremastinos Peripheral vein plasma endothelin-1 levels during coronary angioplasty increase only in normotensive patients Cardiovasc. Drugs Ther. 8 1994 775 777
13. Z.S. Kyriakides, M. Markianos, E.K. Iliodromitis, and D.T. Kremastinos Vein plasma endothelin-1 and cyclic GMP increase during coronary angioplasty is related to myocardial ischaemia Eur. Heart J. 16 1995 894 898
14. A. Franco-Cereceda, L.G. Grip, E. Moor, M. Velander, J. Liska, and J.M. Lundberg Influence of percutaneous transluminal coronary angioplasty on cardiac release of endothelin, neuropeptide Y and noradrenaline Int. J. Cardiol. 48 1995 231 233
15. Z.S. Kyriakides, M. Markianos, I.A. Paraskevaidis, D. Tousoulis, N.K. Fragakis, and D.T. Kremastinos Decreased vasomotor effect of endothelin on the coronary arteries during angioplasty in hypertensive patients Int. J. Cardiol. 55 1996 41 48
16. J. Vojacek, O. Lisy, and S. Simek Local changes in the plasma endothelin level in the coronary artery immediately after percutaneous transluminal coronary angioplasty Cardiology 88 1997 1 5
17. O. Avizohar, E. Karnieli, Z.A. Shen-Orr, B. Rappaport, and R. Beyar Plasma endothelin levels as a function of coronary artery manipulation during balloon angioplasty and high-speed rotational atherectomy Int. J. Cardiovasc. Interv. 1 1998 93 98
18. D. Kruger, E. Giannitsis, A. Sheikhzadeh, and U. Stierle Cardiac release and kinetics of endothelin after uncomplicated percutaneous transluminal coronary angioplasty Am. J. Cardiol. 81 1998 1421 1426
19. A.S. Petronio, G. Amoroso, and U. Limbruno Endothelin-1 release from atherosclerotic plaque after percutaneous transluminal coronary angioplasty in stable angina pectoris and single-vessel coronary artery disease Am. J. Cardiol. 84 1999 1085 1088 A9
20. Y. Hojo, U. Ikeda, and T. Katsuki Release of endothelin 1 and angiotensin II induced by percutaneous transluminal coronary angioplasty Catheter. Cardiovasc. Interv. 51 2000 42 49
21. H. Suzuki, Y. Takeyama, and H. Matsubara Plasma endothelin-1 and thrombomodulin levels in coronary sinus during right atrial pacing and percutaneous transluminal coronary angioplasty Int. J. Cardiol. 74 2000 15 23
22. M.V. Wainstein, S.C. Goncalves, and A.J. Zago Plasma endothelin-1 levels after coronary stenting in humans Am. J. Cardiol. 92 2003 1211 1214
23. W.M. Jackman, X.Z. Wang, and K.J. Friday Catheter ablation of accessory atrioventricular pathways (Wolff-Parkinson-White syndrome) by radiofrequency current N. Engl. J. Med. 324 1991 1605 1611
24. H. Calkins, J. Langberg, and J. Sousa Radiofrequency catheter ablation of accessory atrioventricular connections in 250 patients. Abbreviated therapeutic approach to Wolff-Parkinson-White syndrome Circulation 85 1992 1337 1346
25. G.N. Kay, A.E. Epstein, S.M. Dailey, and V.J. Plumb Role of radiofrequency ablation in the management of supraventricular arrhythmias: experience in 760 consecutive patients J. Cardiovasc. Electrophysiol. 4 1993 371 389
26. A.S. Manolis, P.J. Wang, and N.A. Estes III Radiofrequency catheter ablation for cardiac tachyarrhythmias Ann. Intern. Med. 121 1994 452 461
27. M.M. Scheinman NASPE survey on catheter ablation Pacing Clin. Electrophysiol. 18 1995 1474 1478
28. A.S. Manolis, P.J. Wang, and N.A. Estes III Radiofrequency ablation of left-sided accessory pathways: transaortic versus transseptal approach Am. Heart J. 128 1994 896 902
29. A.S. Manolis, P.J. Wang, and N.A. Estes III Radiofrequency ablation of slow pathway in patients with atrioventricular nodal reentrant tachycardia. Do arrhythmia recurrences correlate with persistent slow pathway conduction or site of successful ablation? Circulation 90 1994 2815 2819
30. A.S. Manolis, P.J. Wang, and N.A. Estes III Radiofrequency ablation of atrial insertion of left-sided accessory pathways guided by the "W Sign" J. Cardiovasc. Electrophysiol. 6 1995 1068 1076
31. G.F. M.D.Lesh, D.J. Van Hare, and D.J. Schamp Curative percutaneous catheter ablation using radiofrequency energy for accessory pathways in all locations: results in 100 consecutive patients J. Am. Coll. Cardiol. 19 1992 1303 1309
32. M.M. Scheinman North American Society of Pacing and Electrophysiology (NASPE) survey on radiofrequency catheter ablation: implications for clinicians, third party insurers, and government regulatory agencies Pacing Clin. Electrophysiol. 15 1992 2228 2231
33. D. Katritsis, M. Hossein-Nia, and A. Anastasakis Use of troponin-T concentration and kinase isoforms for quantitation of myocardial injury induced by radiofrequency catheter ablation Eur. Heart J. 18 1997 1007 1013
34. D.G. Katritsis, M. Hossein-Nia, and A. Anastasakis Myocardial injury induced by radiofrequency and low energy ablation: a quantitative study of CK isoforms, CK-MB, and troponin-T concentrations Pacing Clin. Electrophysiol. 21 1998 1410 1416
35. A.H. Madrid, J.M. del Rey, and J. Rubi Biochemical markers and cardiac troponin I release after radiofrequency catheter ablation: approach to size of necrosis Am. Heart J. 136 1998 948 955
36. A.S. Manolis, V. Vassilikos, and T. Maounis Detection of myocardial injury during radiofrequency catheter ablation by measuring serum cardiac troponin I levels: procedural correlates J. Am. Coll. Cardiol. 34 1999 1099 1105
37. O. Saetrum Opgaard, M. Adner, and T.H. Peters Endocardial expression and functional characterization of endothelin-1 Mol. Cell. Biochem. 224 2001 151 158
38. F. Duru, M. Barton, T.F. Luscher, and R. Candinas Endothelin and cardiac arrhythmias: do endothelin antagonists have a therapeutic potential as antiarrhythmic drugs? Cardiovasc. Res. 49 2001 272 280
39. E.L. Schiffrin, and G. Thibault Plasma endothelin in human essential hypertension Am. J. Hypertens. 4 1991 303 308
40. D. Hasdai, D.R. Holmes Jr., K.N. Garratt, W.D. Edwards, and A. Lerman Mechanical pressure and stretch release endothelin-1 from human atherosclerotic coronary arteries in vivo Circulation 95 1997 357 362
41. C. Mammana, G. Zusso, and C. Tamburino Endothelin-1 variation in the coronary circulation during angioplasty with a stent implant Cardiologia 43 1998 1083 1088
42. B. Merkely, T. Szabo, and L. Geller The selective endothelin-A-receptor antagonist LU 135.252 inhibits the direct arrhythmogenic action of endothelin-1 J. Cardiovasc. Pharmacol. 36 2000 S314 S316